MedCity News July 16, 2024
Ryan Brown

As the clinical trial landscape evolves, prioritizing inclusion, innovation, and scalability is essential for accelerating the development of safe and effective treatments that truly meet the needs of diverse patient populations.

In the dynamic field of clinical research, three critical priorities stand out: inclusion, innovation, and scalability. As the industry strives to develop safe and effective treatments that cater to diverse patient populations, the need for inclusive, cutting-edge, and globally accessible clinical trials has never been more pressing.

Inclusion is at the forefront, as teams strive to design accessible trials informed by epidemiology that accurately represent diverse patient populations. Innovation is another key focus, with clinical trial teams adopting cutting-edge technologies such as AI and wearable devices to transform every...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Amy Abernethy, former No. 2 at FDA, outlines new company’s plans to streamline clinical research
Eximia Research acquires Integrated Clinical Trial Services
Managing Data from Clinical Trials: Q&A with Rust Felix
Revolutionizing Pharma: The Power of AI and Chatbots in Clinical Trials and Beyond
Key End Points in Clinical Trials

Share This Article